The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Ultrasensitive and Selective Electrochemical Diagnosis of Breast Cancer Based on a Hydrazine–Au Nanoparticle–Aptamer Bioconjugate
Abstract
Human epidermal growth factor receptor 2 (HER2) and HER2-overexpressing breast cancer cells were detected using an electrochemical immunosensor combined with hydrazine and aptamer-conjugated gold nanoparticles (AuNPs). The sensor probe was fabricated by covalently immobilizing anti-HER2 onto a nanocomposite layer that was composed of self-assembled 2,5-bis(2-thienyl)-1H-pyrrole-1-(p-benzoic acid) (DPB) on AuNPs. The hydrazine-AuNP-aptamer bioconjugate, where the hydrazine reductant was directly attached onto AuNPs to avoid the nonspecific deposition of silver on the sensor surface, was designed and used to reduce silver ion for signal amplification selectively. The silver-stained target cells were visualized easily by the bare eye and an optical microscope, and the cells were quantitatively analyzed using stripping voltammetry. The parameters affecting the analytical response were optimized. The proposed sensor was capable of differentiating between HER2-positive breast cancer cells and HER2-negative cells. This method exhibited an excellent diagnosis method for the ultrasensitive detection of SK-BR-3 breast cancer cells in human serum samples with a detection limit of 26 cells/mL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
Scanometric DNA Array Detection with Nanoparticle Probes
Taton, T. A., Mirkin, C. A., & Letsinger, R. L. (2000) · Science · doi:10.1126/science.289.5485.1757 · Cited by 2,411
Owens, M. A., Horten, B. C., & Da Silva, M. M. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.011 · Cited by 657
Biosensors for cancer markers diagnosis
Tothill, I. E. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.01.015 · Cited by 552
Trastuzumab-Related Cardiotoxicity: Calling Into Question the Concept of Reversibility
Telli, M. L., Hunt, S. A., Carlson, R. W., & Guardino, A. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0106 · Cited by 385
Breast cancer cell lines: friend or foe?
Burdall, S. E., Hanby, A. M., Lansdown, M. R., & Speirs, V. (2003) · Breast Cancer Research · doi:10.1186/bcr577 · Cited by 322
Nickel, U., zu Castell, A., Pöppl, K., & Schneider, S. (2000) · Langmuir · doi:10.1021/la000536y · Cited by 283
Lu, W., Arumugam, S. R., Senapati, D., Singh, A. K., Arbneshi, T., Khan, S. A., Yu, H., & Ray, P. C. (2010) · ACS Nano · doi:10.1021/nn901742q · Cited by 238
Graphene Oxide Sheet-Mediated Silver Enhancement for Application to Electrochemical Biosensors
Wan, Y., Wang, Y., Wu, J., & Zhang, D. (2011) · Analytical Chemistry · doi:10.1021/ac103047c · Cited by 175
Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles.
Hung, M. C., Schechter, A. L., Chevray, P. Y., Stern, D. F., & Weinberg, R. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.261 · Cited by 159
Affibody-based nanoprobes for HER2-expressing cell and tumor imaging
Gao, J., Chen, K., Miao, Z., Ren, G., Chen, X. S., Gambhir, S. S., & Cheng, Z. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.053 · Cited by 138
Current technologies for HER2 testing in breast cancer
Moelans, C. B., de Weger, R. A., van der Wall, E., & van Diest, P. J. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.12.005 · Cited by 134
In Vitro Selection of RNA Aptamer and Specific Targeting of ErbB2 in Breast Cancer Cells
Kim, M. Y., & Jeong, S. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0283 · Cited by 89
Hydrazine-Catalyzed Ultrasensitive Detection of DNA and Proteins
Shiddiky, M. J. A., Rahman, M. A., & Shim, Y. (2007) · Analytical Chemistry · doi:10.1021/ac0710127 · Cited by 87
Self-citationLoo, L., Capobianco, J. A., Wu, W., Gao, X., Shih, W. Y., Shih, W., Pourrezaei, K., Robinson, M. K., & Adams, G. P. (2011) · Analytical Chemistry · doi:10.1021/ac103301r · Cited by 86
Zhu, Y., Son, J. I., & Shim, Y. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.08.023 · Cited by 74
Self-citationLi, K., Zhan, R., Feng, S., & Liu, B. (2011) · Analytical Chemistry · doi:10.1021/ac102949u · Cited by 57
Koh, W. C. A., Son, J. I., Choe, E. S., & Shim, Y. (2010) · Analytical Chemistry · doi:10.1021/ac102041u · Cited by 52
Self-citation
Cited by
Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules
Labib, M., Sargent, E. H., & Kelley, S. O. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00220 · Cited by 976
Nanotechnology in cancer diagnosis: progress, challenges and opportunities
Zhang, Y., Li, M., Gao, X., Chen, Y., & Liu, T. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0833-3 · Cited by 510
Mittal, S., Kaur, H., Gautam, N., & Mantha, A. K. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.08.028 · Cited by 295
Metadata
- Authors
- Zhu, Y., Chandra, P., & Shim, Y.-B.
- Venue
- Analytical Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-12-19
- Volume
- 85
- Issue
- 2
- Pages
- 1058-1064
- ISSN
- 0003-2700 (ISSN-L)
- 1520-6882
- OpenAlex
- W2317342447
- Cited by
- 301
- References
- 19
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.